Literature DB >> 25773572

Common variable immunodeficiency and pulmonary amyloidosis: a case report.

Sevket Arslan1, Ramazan Ucar, Dudu Mehmet Yavsan, Hasan Esen, Emin Maden, Ismail Reisli, Ahmet Zafer Calıskaner.   

Abstract

Common variable immunodeficiency is the most common symptomatic primary immune deficiency characterized by hypogammaglobulinemia, recurrent infections, and increased risk of autoimmune disease and malignancy. Secondary amyloidosis develops from chronic inflammatory conditions. The co-existence of CVID (especially in patients with bronchiectasis) and secondary amyloidosis has been reported rarely. We describe the first case of pulmonary hypertension secondary to pulmonary amyloidosis in a patient with CVID.

Entities:  

Mesh:

Year:  2015        PMID: 25773572     DOI: 10.1007/s10875-015-0151-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  13 in total

Review 1.  Pulmonary complications of common variable immunodeficiency.

Authors:  Paula J Busse; Sherry Farzan; Charlotte Cunningham-Rundles
Journal:  Ann Allergy Asthma Immunol       Date:  2007-01       Impact factor: 6.347

2.  Novel NLRP12 mutations associated with intestinal amyloidosis in a patient diagnosed with common variable immunodeficiency.

Authors:  Stephan Borte; Mehmet Halil Celiksoy; Volker Menzel; Ozan Ozkaya; Fatma Zeynep Ozen; Lennart Hammarström; Alisan Yildiran
Journal:  Clin Immunol       Date:  2014-07-23       Impact factor: 3.969

3.  Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993.

Authors:  J P Utz; S J Swensen; M A Gertz
Journal:  Ann Intern Med       Date:  1996-02-15       Impact factor: 25.391

4.  Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid.

Authors:  R R Smith; G M Hutchins; G W Moore; R L Humphrey
Journal:  Am J Med       Date:  1979-01       Impact factor: 4.965

Review 5.  "A rose is a rose is a rose," but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011?

Authors:  Patrick F K Yong; James E D Thaventhiran; Bodo Grimbacher
Journal:  Adv Immunol       Date:  2011       Impact factor: 3.543

Review 6.  Amyloidosis.

Authors:  Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Suzanne R Hayman
Journal:  Best Pract Res Clin Haematol       Date:  2005       Impact factor: 3.020

7.  Association of secondary amyloidosis with common variable immune deficiency and tuberculosis.

Authors:  Aykut Ferhat Celik; Mehmet Riza Altiparmak; Gülsüm Emel Pamuk; Omer Nuri Pamuk; Fehmi Tabak
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

8.  A hepatitis C-positive patient with new onset of nephrotic syndrome and systemic amyloidosis secondary to common variable immunodeficiency.

Authors:  Kultigin Turkmen; Melih Anil; Yalcin Solak; Huseyin Atalay; Hasan Esen; Halil Z Tonbul
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

9.  Clinical characteristics of amyloidosis with isolated respiratory system involvement: A review of 13 cases.

Authors:  Haiqing Chu; Lan Zhao; Zhemin Zhang; Tao Gui; Xianghua Yi; Xiwen Sun
Journal:  Ann Thorac Med       Date:  2012-10       Impact factor: 2.219

10.  A Rare Cause of Diffuse Parenchymal Lung Disease together with Granulomatous Reaction: Pulmonary Amyloidosis.

Authors:  Zuhal Ozer Simsek; Fatma Sema Oymak; Nuri Tutar; Ozlem Canoz; Ramazan Demir
Journal:  Case Rep Pulmonol       Date:  2013-02-28
View more
  3 in total

1.  Pulmonary arterial hypertension due to pulmonary vascular amyloid deposition in a patient with multiple myeloma.

Authors:  Hirotsugu Hashimoto; Atsushi Kurata; Hideaki Mizuno; Tamaki Nashiro; Akira Hangaishi; Masahiko Kuroda; Kensuke Usuki; Hajime Horiuchi
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Evidence of pulmonary arterial hypertension in two patients with common variable immunodeficiency.

Authors:  Jessica Huston; Joyce Johnson; Anna Hemnes; Meredith Pugh
Journal:  Pulm Circ       Date:  2020-05-01       Impact factor: 3.017

3.  CVID Associated with Systemic Amyloidosis.

Authors:  Saliha Esenboga; Deniz Çagdas Ayvaz; Arzu Saglam Ayhan; Banu Peynircioglu; Ozden Sanal; Ilhan Tezcan
Journal:  Case Reports Immunol       Date:  2015-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.